Related references
Note: Only part of the references are listed.Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model
Farshad Mirzavi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Lipid-based nanoparticulate delivery systems for HER2-positive breast cancer immunotherapy
Nima Behravan et al.
LIFE SCIENCES (2022)
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2022)
Improving potency of Nanoliposomal AE36 peptide vaccine by adding CD4+T cell helper epitope and MPL in TUBO breast cancer mice model
Parvin Zamani et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)
Preventive cancer vaccination with P5 HER-2/neo-derived peptide-pulsed peripheral blood mononuclear cells in a mouse model of breast cancer
Mahdi Dehghan-Manshadi et al.
BIOCHEMISTRY AND CELL BIOLOGY (2021)
Vaccines targeting angiogenesis in melanoma
Fatemeh Zahedipour et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Considerations for the delivery of STING ligands in cancer immunotherapy
M. Petrovic et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model
Mona Yazdani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy
Sanaz Keshavarz Shahbaz et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma
Mona Yazdani et al.
VACCINE (2020)
Engineering nanoparticulate vaccines for enhancing antigen cross-presentation
Guangsheng Du et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
Zili Gu et al.
PHARMACEUTICS (2020)
Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications
Eiji Yuba
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Many ways to resistance: How melanoma cells evade targeted therapies
Ines Kozar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer
Parvin Zamani et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Peptides as cancer vaccines
Marta Calvo Tardon et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8+ T Cell Responses
Cheol Gyun Kim et al.
PHARMACEUTICS (2019)
A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway
Yue-Li Sun et al.
BMC CANCER (2019)
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
Atefeh Arab et al.
JOURNAL OF DRUG TARGETING (2018)
Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
Sara Nikoofal-Sahlabadi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy
Parvin Zamani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Peptide Delivery Systems for Cancer Vaccines
Xuedan He et al.
ADVANCED THERAPEUTICS (2018)
Melanoma treatment in review
Beatriz Domingues et al.
IMMUNOTARGETS AND THERAPY (2018)
Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
Jie Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Peptide vaccines in cancer - old concept revisited
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
Signe Tandrup Schmidt et al.
PHARMACEUTICS (2016)
Genomic classification of cutaneous melanoma
Ian R. Watson et al.
CANCER RESEARCH (2015)
Nanoliposome-mediated targeting of antibodies to tumors: IVIG antibodies as a model
Amin Reza Nikpoor et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome
Shoichi Hazama et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
Hisae Iinuma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
K. Yoshimura et al.
BRITISH JOURNAL OF CANCER (2013)
Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing
Shengli Song et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Hiroyuki Suzuki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
Toru Masuzawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
Motoki Miyazawa et al.
CANCER SCIENCE (2010)
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Janice M. Mehnert et al.
HUMAN PATHOLOGY (2010)
Strategies for Cancer Vaccine Development
Matteo Vergati et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation
Roger Belizaire et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Angiogenesis in melanoma
Ganapati H. Mahabeleshwar et al.
SEMINARS IN ONCOLOGY (2007)
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Robert Roskoski
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Optimizing dosage of ketamine and xylazine in murine echocardiography
Qi Xu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Natural selection of tumor variants in the generation of tumor escape phenotypes
HT Khong et al.
NATURE IMMUNOLOGY (2002)
Share Paper
